Additional file 3: of Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
- Alexandre Mebazaa (58728)
- Christopher Geven (6116486)
- Alexa Hollinger (4890262)
- Xavier Wittebole (55860)
- Benjamin Chousterman (4873984)
- Alice Blet (3412007)
- Etienne Gayat (159635)
- Oliver Hartmann (357518)
- Paul Scigalla (3497951)
- Joachim Struck (15613)
- Andreas Bergmann (15614)
- Massimo Antonelli (8610)
- Albertus Beishuizen (70118)
- Jean-Michel Constantin (20671)
- Charles Damoisel (744993)
- Nicolas Deye (3418184)
- Salvatore Di Somma (658151)
- Thierry Dugernier (3445457)
- Bruno François (5594450)
- Stephane Gaudry (6116489)
- Vincent Huberlant (6116492)
- Jean-Baptiste Lascarrou (5514221)
- Gernot Marx (747251)
- Emmanuelle Mercier (4596301)
- Haikel Oueslati (6116495)
- Peter Pickkers (15648)
- Romain Sonneville (340373)
- Matthieu Legrand (159626)
- Pierre-François Laterre (3483311)
Publication date
December 2018
DOIAbstract
Figure S2. Bio-ADM levels at baseline and on day 2 in 28-day survivors and nonsurvivors. If data were missing at day 2 (e.g., owing to death or discharge; 12.7%), the last available measurement was carried forward. Horizontal lines at 70 and 130Â pg/ml for better orientation; y-axis is truncated at 300Â pg/ml. (TIF 206 kb
Add to ORKG